Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...
Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.
Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, today announced the launch of Ibex 4 ...
Researchers introduce a high-throughput scanner with AI-based quality control, enabling faster slide processing, reduced rework, and improved consistency in pathology workflows.
Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence ...
Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most ...
Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with ...
When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results